Cystic mesothelioma ... and is characterized by the presence of multiple cysts. Peritoneal inclusion cysts, on the other hand, are fluid-filled sacs that can develop in the peritoneal cavity ...

Britain is facing an avalanche of asbestos-related deaths. For decades, the official policy of successive governments has been to leave asbestos where it is, provided it is sealed in, painted over ...

Malignant pleural mesothelioma ... MPM cell cultures are a promising and faithful ex vivo model of MPM. Due to the complexity and heterogeneity of MPM, a biomarker-driven approach to therapy is likely ...

However, early detection of mesothelioma is key to extending your life expectancy. Mesothelioma takes several decades to develop. When a patient does begin to show symptoms, they’re usually mild but ...

Mesothelioma is a rare form of cancer that starts in the lining of the major organs. It is linked with exposure to asbestos. Most people develop mesothelioma in the lining of their lungs (pleural ...

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...

We are pleased to announce the dosing of the first patient in our Phase I ISM6331 clinical trial in mesothelioma and other ... and survival of tumor cells through blocking the transcription ...

Immunotherapies using the patient’s own immune defenses to combat cancer are on the forefront, along with targeted therapies that focus on exploiting some weaknesses in mesothelioma cells and gene ...

PURPOSE OF REVIEW: Malignant mesothelioma is an asbestos-induced, aggressive tumour. In centres across the world, research has focused on evaluating biomarkers for malignant mesothelioma screening ...

Thanks to a new technology called Moscot ("Multi-Omics Single-Cell Optimal Transport"), researchers can now observe millions of cells simultaneously as they develop into a new organ—for example ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.